RVL Pharmaceuticals plc Royalty Expense
RVL Pharmaceuticals plc reported Royalty Expense of $500.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2022-03-30
- RVL Pharmaceuticals plc royalty expense for fiscal 2021 was $500.00K.
| Period end | Royalty Expense 12 month |
|---|---|
| 2021-12-31 | $500.00K 10-K · filed 2022-03-30 |